Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F73SC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,194
Award facts
- Contract value 100% obligated
- $19,193.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,193.78 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune diseases. The contract, awarded on January 6, 2026, with an ultimate completion date of January 7, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under a larger indefinite delivery contract vehicle with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly known as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement. The company supplies a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems through the Defense Logistics Agency and other federal healthcare entities. All of AmerisourceBergen's reviewed contract awards with the DLA have been competitively awarded and non-set-aside, demonstrating the company's capability to meet federal procurement requirements through open competition across diverse product categories and transaction values.
Quick answers
Who was awarded contract SPE2DR26F73SC?
SPE2DR26F73SC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F73SC worth?
The government has obligated $19,194 on SPE2DR26F73SC.
Is contract SPE2DR26F73SC an order under another contract?
Yes. SPE2DR26F73SC is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73SC competed?
The extent of competition for SPE2DR26F73SC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award